SCHEMBL6713093

SCHEMBL6713093

CC(C)c1ccc(OC(Cc2ccc(O)cc2)C(=O)O)cc1

nearest known ligand 0.64

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PPARG P37231 20/20 0.64
PPARA Q07869 18/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6716295 1.00 PPARG (0.64) PPARGPPARA
SCHEMBL6713091 1.00 PPARG (0.64) PPARGPPARA
SCHEMBL5610143 0.85 PPARG (0.76) PPARGPPARA
SCHEMBL5610135 0.85 PPARG (0.76) PPARGPPARA
SCHEMBL6715218 0.85 L3MBTL1 (0.48) PPARGPPARA
SCHEMBL6556100 0.83 PPARG (0.73) PPARGPPARA
SCHEMBL5609118 0.82 PPARG (0.78) PPARGPPARA
SCHEMBL5609132 0.82 PPARG (0.78) PPARGPPARA
SCHEMBL5609291 0.82 PPARG (0.59) PPARGPPARA
SCHEMBL5609279 0.82 PPARG (0.59) PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885PPARA 71/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.